Aspen set to take over Strides' Latina unit

The chief executive of Aspen Pharmacare Holdings, Stephen Saad, told Bloomberg that the South African generic drug major plans to buy the  remaining 50% of Indian generic firm Stride Arcolabs' Latin American  business that it does not already own. The size of the deal, which he  expects to be complete by the end of the first half, will depend on the  unit's income prospects.

Strides has 13 plants across India, Singapore, Brazil, Mexico, Poland  and Italy. In 2007, Aspen bought 50% of Strides' Latin American unit for  $152.5 million.